IART financials
Integra LifeSciences (IART) financials: revenue, profit and margins by year and quarter, the balance sheet and cash flow.
IART income statement, yearly
| Year | Revenue | Gross profit | Operating income | Net income | EPS |
|---|---|---|---|---|---|
| 2025 | $1.64B | $845.23M | $68.32M | -$516.47M | -6.73 |
| 2024 | $1.61B | $882.06M | $28.41M | -$6.94M | -0.09 |
| 2023 | $1.54B | $884.74M | $111.53M | $67.74M | 0.84 |
| 2022 | $1.56B | $970.31M | $238.92M | $180.55M | 2.16 |
| 2021 | $1.54B | $944.64M | $197.23M | $169.07M | 1.98 |
| 2020 | $1.37B | $851.03M | $151.37M | $133.89M | 1.57 |
- IART revenue was $1.64B in fiscal 2025, net income -$516.47M.
Updated 2026-11-03 11:32 UTC